Agios PharmEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 35.99 USD | 46 USD | 22,24 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 42,375 USD | 3 | 3 | 3 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 59.471.609 | 11,26 | 5,44 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Agios Pharm
Mitarbeiter 539
Handelsplatz NASDAQ
Ticker Symbol AGIO
IPO Datum 2013-07-24
Adresse 88 Sidney Street, Cambridge, MA, United States, 02139
Webseite https://www.agios.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Brian M. Goff M.B.A. | CEO & Director |
| 2 | Ms. Cecilia Jones | Chief Financial Officer |
| 3 | Dr. Krishnan Viswanadhan M.B.A., Pharm.D. | Chief Strategy & Operations Officer |
| 4 | Mr. James William Burns | Chief Legal Officer |
| 5 | Dr. Sarah Gheuens M.D., Ph.D. | Chief Medical Officer and Head of Research & Development |
| 6 | Dr. Lewis clayton Cantley Ph.D. | Co-Founder |
| 7 | Dr. Tak Wah Mak D.Sc., FRSC, Ph.D. | Co-Founder |
| 8 | Dr. Craig B. Thompson M.D. | Co-Founder |
| 9 | Dr. Shin-San Su Ph.D. | Co-Founder |
| 10 | Mr. T. J. Washburn | VP, Controller & Principal Accounting Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Farallon Capital Management, L.L.C. | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 5 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Erste Asset Management GmbH | 0,00% | 0,00 Mio. USD |
| 7 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Lynx1 Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 10 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | BNP Paribas Investment Partners SA | 0,00% | 0,00 Mio. USD |
| 12 | Delaware Management Holdings Inc | 0,00% | 0,00 Mio. USD |
| 13 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 14 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Susquehanna International Group, LLP | 0,00% | 0,00 Mio. USD |
| 16 | MPM Oncology Impact Management LP | 0,00% | 0,00 Mio. USD |
| 17 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 18 | GW&K Investment Management, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 20 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |